Financial Ratios

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE426.25-5.45 (-1.26 %)
PREV CLOSE ( ) 431.70
OPEN PRICE ( ) 429.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 83360
TODAY'S LOW / HIGH ( )423.20 431.45
52 WK LOW / HIGH ( )279.65 470.9
NSE426.50-4.9 (-1.14 %)
PREV CLOSE( ) 431.40
OPEN PRICE ( ) 429.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 426.50 (145)
VOLUME 1487447
TODAY'S LOW / HIGH( ) 423.50 431.30
52 WK LOW / HIGH ( )278.85 471
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)14.1213.9617.8224.988.92
   CEPS(Rs)19.7018.3421.488.444.80
   DPS(Rs)2.002.002.002.501.50
   Book NAV/Share(Rs)75.0962.8850.45169.41148.96
   Tax Rate(%)27.6823.1024.9912.2921.63
Margin Ratios
   Core EBITDA Margin(%)25.6727.3031.6620.3815.72
   EBIT Margin(%)20.7422.7628.1114.029.26
   Pre Tax Margin(%)18.2120.7226.7310.885.42
   PAT Margin (%)13.1715.9420.059.554.25
   Cash Profit Margin (%)18.3820.9424.1716.1211.43
Performance Ratios
   ROA(%)10.3011.5019.847.703.05
   ROE(%)20.4824.6542.3215.726.14
   ROCE(%)22.2823.5238.6014.418.18
   Asset Turnover(x)0.780.720.990.810.72
   Sales/Fixed Asset(x)1.551.591.911.271.17
   Working Capital/Sales(x)5.426.116.9118.9141.13
Efficiency Ratios
   Fixed Capital/Sales(x)0.650.630.520.790.85
   Receivable days87.1498.8378.7595.56101.35
   Inventory Days102.99124.9392.88101.73101.34
   Payable days103.68170.53151.36143.78119.46
Valuation Parameters
   PER(x)20.7642.2720.322.588.96
   PCE(x)14.8832.1716.857.6516.65
   Price/Book(x)3.909.387.181.902.68
   Yield(%)0.680.340.550.770.38
   EV/Net Sales(x)3.027.074.361.602.35
   EV/Core EBITDA(x)11.6625.4713.527.7714.32
   EV/EBIT(x)14.5931.0715.5011.4125.42
   EV/CE(x)2.274.713.481.221.61
   M Cap / Sales2.736.744.071.231.90
Growth Ratio
   Net Sales Growth(%)22.66-1.2970.4725.1010.33
   Core EBITDA Growth(%)14.61-14.99166.8556.71-16.00
   EBIT Growth(%)11.75-20.09241.8189.42-34.55
   PAT Growth(%)1.37-21.55258.03181.12-45.13
   EPS Growth(%)1.13-21.66-28.67179.88-45.34
Financial Stability Ratios
   Total Debt/Equity(x)0.420.480.510.570.64
   Current Ratio(x)1.371.271.261.091.04
   Quick Ratio(x)0.820.680.690.540.56
   Interest Cover(x)8.2211.1820.344.472.41
   Total Debt/Mcap(x)0.110.050.070.300.24

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.